About Triomics
Triomics is a company based in San Francisco (United States) founded in 2020 by Hrituraj Singh and Sarim Khan. Triomics has raised $50.88 million across 4 funding rounds from investors including Nexus Venture Partners, Lightspeed India and General Catalyst. The company has 29 employees. Triomics offers products and services including Trial Enrollment, Clinical Navigators, and Cancer Registries. Triomics operates in a competitive market with competitors including Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
- Headquarter San Francisco, United States
- Employees 29
- Founders Hrituraj Singh, Sarim Khan
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website triomics.com
- Social LinkedIn X
- Legal Name Triomics Healthcare Private Limited
- Date of Incorporation 20 Oct, 2020
- Annual Revenue₹8.99 Cr
FY 2024 · -73% YoY
- Net Loss-₹8.14 Cr
FY 2024 · -91% margin
- EBITDA-₹7.77 Cr
FY 2024 · -86% margin
- Total Equity Funding$50.88M (USD)
in 4 rounds
- Latest Funding Round$22M (USD), Series B
May 2026
- InvestorsNexus Venture Partners
& 5 more
- Employee Count29
Associated legal entities of Triomics
Triomics operates through Triomics Healthcare Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Triomics Healthcare Private Limited CIN U85300UP2020PTC136648 | Active | 20 Oct 2020 | Surajpur, Uttar Pradesh | ₹9.0 Cr | 37 | 3 | View details |
Products & Services of Triomics
Triomics offers a comprehensive portfolio of products and services, including Trial Enrollment, Clinical Navigators, and Cancer Registries.
Screens patients for ongoing clinical trials using generative AI.
Identifies eligible patients for trials and healthcare operations.
Manages oncology data for business intelligence and precision medicine.
Funding Insights of Triomics
Triomics has successfully raised a total of $50.88M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $22 million completed in May 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $50.88M
- Total Rounds 4
- Last Round Series B — $22M
- First Round $125,000
(Jun 2021)
- Investors Count 6
All 4 funding rounds of Triomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2026 | $22M | Series B | – | Battery Ventures | |
| May 2024 | $15M | Series B | – | – | |
| Dec 2022 | $13.75M | Series A | – | – | – |
| Jun 2021 | $125,000 | Seed | – | Y Combinator | – |
6 investors in total: 6 institutional.
Investors in Triomics
Triomics has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Nexus Venture Partners, Lightspeed India and General Catalyst.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm that partners with entrepreneurs for product-first companies. | 2006 | nexusvp.com | Menlo Park, United States | |
Investment and transformation services for entrepreneurs in technology and finance sectors. | – | generalcatalyst.com | - | |
Early-stage startups are accelerated via funding and educational programs. | – | ycombinator.com | Mountain View, United States | |
Venture capital investing in innovative startups across technology sectors. | 2008 | lsip.com | Bengaluru, India | |
- | – | battery.com | - | |
- | – | lsvp.com | - |
Investor details for Triomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Triomics Healthcare Private Limited (Triomics)
Triomics Healthcare Private Limited is the primary company behind Triomics. The board of Triomics Healthcare Private Limited currently have 3 directors; the longest-serving is Sarim Khan, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sarim Khan DIN 08928070 | Director | 20 Oct 2020 | 5 yrs 11 mo | Triomics Healthcare Private Limited |
| Sajjan Rajpurohit DIN 06913180 | Director | 20 Oct 2020 | 5 yrs 11 mo | Triomics Healthcare Private Limited |
| Hrituraj Singh DIN 09333966 | Director | 28 Sep 2021 | 5 yrs | Triomics Healthcare Private Limited |
People of Triomics
2 people are tracked at Triomics (2 in leadership); the tracked headcount is 29.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder & CEO | Leadership |
Complete people profiles for Triomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Triomics
Figures of Triomics Healthcare Private Limited, the primary company behind Triomics, for FY 2024. Revenue was ₹8.99 Cr (-73% year on year). Net loss was -₹8.14 Cr (-91% margin). EBITDA was -₹7.77 Cr (-86% margin).
- ₹8.99 CrRevenue · FY 2024 · -73% YoY
- -₹8.14 CrNet loss · -91% margin
- -₹7.77 CrEBITDA · -86% margin
- ₹38.3 LakhPaid-up capital
- 37Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Triomics Healthcare Private Limited are on its company page.
Detailed financial statements for Triomics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Triomics
3 dated milestones of Triomics across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Triomics is founded.
- Funding First funding round of $125K.
- Funding Latest funding round, Series B, of $22.0M.
Competitors of Triomics
Triomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medidata.com | 1999 | New York, United States | $41.5M | 1,677 | Medidata is recognized as a leading provider of SaaS solutions for clinical research. | |
| verily.com | 2015 | Dallas, United States | $2.5B | – | AI-based solutions for health management are provided. | |
| trinetx.com | 2013 | Cambridge, United States | $53M | 95 | Clinical trial management software is provided for researchers and professionals. | |
| signanthealth.com | 2000 | Plymouth Meeting, United States | $3.4M | – | Signant Health is engaged in providing clinical trial technology solutions. | |
| wcgclinical.com | 2012 | Princeton, United States | – | 229 | Regulatory and ethical review services for clinical research are provided. | |
| ixico.com | 2004 | London, United Kingdom | – | 93 | AI-based medical image management and analysis solutions for healthcare organizations | |
| deep6.ai | 2013 | Pasadena, United States | $54.79M | 41 | AI enabled solutions for clinical trials | |
| clinicalink.com | 2006 | Winston-salem, United States | $13.15M | 283 | Paperless eSource and patient engagement solutions for clinical trials | |
| massivebio.com | 2014 | New York, United States | $14.13M | – | Provider of AI-based clinical trial management tool |
Detailed competitors of Triomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Triomics
The website of Triomics (triomics.com) receives about 3.8K visits a month.
- Monthly visits3.8K
▼ 34.5% vs previous month
Websites whose visitors overlap most with Triomics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hpiinc.com | 100% | 11.8K | #2,067,910 | View details | |
| saveo.in | 53% | 6.3K | #2,613,705 | View details | |
| coursejoiner.com | 46% | – | #290,163 | View details | |
cardeahealthcare.in | cardeahealthcare.in | 25% | – | – | – |
| innaccel.com | 25% | 1.1K | #12,260,392 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Triomics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Triomics
Complete news archive for Triomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Triomics
10 companies that operate in the same segment as Triomics (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Triomics
Triomics was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Triomics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Sarim Khan is the current CEO of Triomics. They have also founded this company.
Triomics is a funded company, having raised a total of $50.88M across 4 funding rounds to date. The company's 1st funding round was a Seed of $125K, raised on Jun 2021.
Triomics has 29 employees.
The primary company behind Triomics, Triomics Healthcare Private Limited, reported revenue of ₹8.99 Cr for FY 2024, down 73% year on year.
Triomics was founded in 2020 in San Francisco, United States, within the health technology sector. An end-to-end platform is offered for managing clinical trials, where workflows for clinical care and research are integrated. Inefficiencies in data collection, patient recruitment, and related operational tasks are addressed through the software, supporting streamlined processes in clinical research operations.
Triomics offers Trial Enrollment, Clinical Navigators, and Cancer Registries.
Triomics has 6 investors. Key investors include Nexus Venture Partners, Lightspeed India, General Catalyst, Y Combinator, and Battery Ventures.
Triomics operates through Triomics Healthcare Private Limited.
The legal entities of Triomics currently have 3 directors, including Hrituraj Singh, Sarim Khan, Sajjan Rajpurohit.